These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 16290228)

  • 1. Understanding the IL-23-IL-17 immune pathway.
    McKenzie BS; Kastelein RA; Cua DJ
    Trends Immunol; 2006 Jan; 27(1):17-23. PubMed ID: 16290228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis.
    Larsen JM; Bonefeld CM; Poulsen SS; Geisler C; Skov L
    J Allergy Clin Immunol; 2009 Feb; 123(2):486-92. PubMed ID: 18986691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
    Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
    Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the development and effector functions of TH17 cells.
    Ghilardi N; Ouyang W
    Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
    Martin-Orozco N; Dong C
    Curr Opin Investig Drugs; 2009 Jun; 10(6):543-9. PubMed ID: 19513943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.
    Volpe E; Servant N; Zollinger R; Bogiatzi SI; Hupé P; Barillot E; Soumelis V
    Nat Immunol; 2008 Jun; 9(6):650-7. PubMed ID: 18454150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S; Cavoy R; Goldman M
    Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
    Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
    Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
    Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23/IL-17 biology and therapeutic considerations.
    Dong C
    J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cell induction and immune regulatory effects.
    Bi Y; Liu G; Yang R
    J Cell Physiol; 2007 May; 211(2):273-8. PubMed ID: 17311299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.
    Murphy CA; Langrish CL; Chen Y; Blumenschein W; McClanahan T; Kastelein RA; Sedgwick JD; Cua DJ
    J Exp Med; 2003 Dec; 198(12):1951-7. PubMed ID: 14662908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
    Kikly K; Liu L; Na S; Sedgwick JD
    Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of the Th17 pathway and its role in host defense.
    O'Quinn DB; Palmer MT; Lee YK; Weaver CT
    Adv Immunol; 2008; 99():115-63. PubMed ID: 19117534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease.
    Cardoso CR; Garlet GP; Crippa GE; Rosa AL; Júnior WM; Rossi MA; Silva JS
    Oral Microbiol Immunol; 2009 Feb; 24(1):1-6. PubMed ID: 19121062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.